Conditions: Fibromyalgia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 747
Healthy volunteers: no

Brief summary:
This study, will compare pregabalin with placebo for the duration of 14 weeks to evaluate the efficacy and safety of pregabalin in patients with fibromyalgia.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: pregabalin intervention 2: pregabalin intervention 3: pregabalin intervention 4: placebo
Intervention descriptions: intervention 1: 600mg/day intervention 2: 450mg/day intervention 3: 300mg/day intervention 4: placebo

Protocol document: